Jeffrey Che-Wei Kang

Title: Innovations by Jeffrey Che-Wei Kang

Introduction

Jeffrey Che-Wei Kang is an accomplished inventor based in College Station, TX (US). He has made significant contributions to the field of targeted drug delivery, particularly in the development of endolysosomal targeting conjugates. His innovative work aims to improve the efficiency of delivering cargo molecules to specific cellular compartments, which is crucial in therapeutic applications.

Latest Patents

Kang holds a patent for "Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells." This patent describes engineered endolysosomal targeting conjugates designed to deliver cargo molecules, such as cytotoxic drugs or imaging labels, with enhanced efficiency to late endosomes and/or lysosomes in target cells, including tumor cells. The conjugate comprises a targeting component that binds to a cell surface molecule of a target cell and a cargo component that includes the cargo molecule. The targeting component may be covalently or non-covalently bonded to the cargo component, ensuring higher affinity binding in the extracellular space compared to the endolysosomal compartment.

Career Highlights

Throughout his career, Jeffrey Che-Wei Kang has been associated with prestigious institutions such as the Texas A&M University System and the University of Texas System. His work has focused on advancing the field of drug delivery systems, contributing to both academic research and practical applications in medicine.

Collaborations

Kang has collaborated with notable colleagues, including Ran Li and Elizabeth Sally Ward Ober. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.

Conclusion

Jeffrey Che-Wei Kang's innovative contributions to endolysosomal targeting conjugates represent a significant advancement in drug delivery technology. His work continues to influence the field and holds promise for future therapeutic applications.